company background image
512 logo

Grand Pharmaceutical Group SEHK:512 Stok Raporu

Son Fiyat

HK$4.56

Piyasa Değeri

HK$16.0b

7D

-1.7%

1Y

1.3%

Güncellenmiş

04 Nov, 2024

Veri

Şirket Finansalları +

Grand Pharmaceutical Group Limited

SEHK:512 Stok Raporu

Piyasa değeri: HK$16.0b

512 Stoklara Genel Bakış

Bir yatırım holding şirketi olan Grand Pharmaceutical Group Limited, farmasötik preparatlar ve tıbbi cihazlar, biyoteknoloji ve sağlık ürünleri ve farmasötik hammaddelerin araştırma ve geliştirme, üretim ve satışını yapmaktadır.

Grand Pharmaceutical Group Limited Rakipler

Fiyat Geçmişi ve Performans

için tüm zamanların en yüksek seviyelerinin, değişikliklerin ve fiyat düşüşlerinin özeti Grand Pharmaceutical Group
Tarihsel hisse senedi fiyatları
Güncel Hisse FiyatıHK$4.56
52 Haftanın En Yüksek SeviyesiHK$5.62
52 Haftanın En Düşük SeviyesiHK$3.17
Beta0.71
11 Aylık Değişim-12.31%
3 Aylık Değişim4.83%
1 Yıllık Değişim1.33%
33 Yıllık Değişim-23.10%
5 Yıllık Değişim0.22%
Halka arzdan bu yana değişim-82.46%

Son Haberler & Güncellemeler

Grand Pharmaceutical Group Limited (HKG:512) Looks Inexpensive But Perhaps Not Attractive Enough

Sep 19
Grand Pharmaceutical Group Limited (HKG:512) Looks Inexpensive But Perhaps Not Attractive Enough

Recent updates

Grand Pharmaceutical Group Limited (HKG:512) Looks Inexpensive But Perhaps Not Attractive Enough

Sep 19
Grand Pharmaceutical Group Limited (HKG:512) Looks Inexpensive But Perhaps Not Attractive Enough

Grand Pharmaceutical Group (HKG:512) Is Paying Out A Larger Dividend Than Last Year

Jun 05
Grand Pharmaceutical Group (HKG:512) Is Paying Out A Larger Dividend Than Last Year

Market Participants Recognise Grand Pharmaceutical Group Limited's (HKG:512) Earnings

May 22
Market Participants Recognise Grand Pharmaceutical Group Limited's (HKG:512) Earnings

Grand Pharmaceutical Group (HKG:512) Will Pay A Larger Dividend Than Last Year At HK$0.26

Apr 25
Grand Pharmaceutical Group (HKG:512) Will Pay A Larger Dividend Than Last Year At HK$0.26

Grand Pharmaceutical Group (HKG:512) Will Pay A Larger Dividend Than Last Year At HK$0.26

Mar 25
Grand Pharmaceutical Group (HKG:512) Will Pay A Larger Dividend Than Last Year At HK$0.26

We Think Grand Pharmaceutical Group (HKG:512) Can Stay On Top Of Its Debt

Oct 20
We Think Grand Pharmaceutical Group (HKG:512) Can Stay On Top Of Its Debt

Here's Why We Think Grand Pharmaceutical Group (HKG:512) Is Well Worth Watching

Sep 26
Here's Why We Think Grand Pharmaceutical Group (HKG:512) Is Well Worth Watching

Grand Pharmaceutical Group's (HKG:512) Dividend Will Be Increased To HK$0.14

Jun 04
Grand Pharmaceutical Group's (HKG:512) Dividend Will Be Increased To HK$0.14

Is Grand Pharmaceutical Group (HKG:512) A Risky Investment?

May 05
Is Grand Pharmaceutical Group (HKG:512) A Risky Investment?

Grand Pharmaceutical Group (HKG:512) Seems To Use Debt Quite Sensibly

Nov 21
Grand Pharmaceutical Group (HKG:512) Seems To Use Debt Quite Sensibly

Is Grand Pharmaceutical Group Limited (HKG:512) Trading At A 43% Discount?

Sep 05
Is Grand Pharmaceutical Group Limited (HKG:512) Trading At A 43% Discount?

Grand Pharmaceutical Group (HKG:512) Seems To Use Debt Quite Sensibly

Aug 16
Grand Pharmaceutical Group (HKG:512) Seems To Use Debt Quite Sensibly

Here's Why We Think Grand Pharmaceutical Group (HKG:512) Is Well Worth Watching

Jul 28
Here's Why We Think Grand Pharmaceutical Group (HKG:512) Is Well Worth Watching

Grand Pharmaceutical Group's (HKG:512) Dividend Will Be HK$0.11

May 29
Grand Pharmaceutical Group's (HKG:512) Dividend Will Be HK$0.11

Is Grand Pharmaceutical Group Limited (HKG:512) Trading At A 45% Discount?

Apr 08
Is Grand Pharmaceutical Group Limited (HKG:512) Trading At A 45% Discount?

Grand Pharmaceutical Group (HKG:512) Has A Rock Solid Balance Sheet

Mar 22
Grand Pharmaceutical Group (HKG:512) Has A Rock Solid Balance Sheet

If You Like EPS Growth Then Check Out Grand Pharmaceutical Group (HKG:512) Before It's Too Late

Jan 24
If You Like EPS Growth Then Check Out Grand Pharmaceutical Group (HKG:512) Before It's Too Late

These 4 Measures Indicate That Grand Pharmaceutical Group (HKG:512) Is Using Debt Safely

Dec 13
These 4 Measures Indicate That Grand Pharmaceutical Group (HKG:512) Is Using Debt Safely

Grand Pharmaceutical Group Limited's (HKG:512) Intrinsic Value Is Potentially 45% Above Its Share Price

Nov 27
Grand Pharmaceutical Group Limited's (HKG:512) Intrinsic Value Is Potentially 45% Above Its Share Price

With EPS Growth And More, China Grand Pharmaceutical and Healthcare Holdings (HKG:512) Is Interesting

Oct 25
With EPS Growth And More, China Grand Pharmaceutical and Healthcare Holdings (HKG:512) Is Interesting

China Grand Pharmaceutical and Healthcare Holdings (HKG:512) Seems To Use Debt Rather Sparingly

Sep 01
China Grand Pharmaceutical and Healthcare Holdings (HKG:512) Seems To Use Debt Rather Sparingly

Do China Grand Pharmaceutical and Healthcare Holdings's (HKG:512) Earnings Warrant Your Attention?

Jul 12
Do China Grand Pharmaceutical and Healthcare Holdings's (HKG:512) Earnings Warrant Your Attention?

Hissedar Getirileri

512HK PharmaceuticalsHK Pazar
7D-1.7%-7.2%-1.0%
1Y1.3%-2.9%15.0%

Getiri vs. Endüstri: 512 exceeded the Hong Kong Pharmaceuticals industry which returned -2.9% over the past year.

Getiri vs Piyasa: 512 underperformed the Hong Kong Market which returned 15% over the past year.

Fiyat Oynaklığı

Is 512's price volatile compared to industry and market?
512 volatility
512 Average Weekly Movement5.5%
Pharmaceuticals Industry Average Movement6.9%
Market Average Movement9.0%
10% most volatile stocks in HK Market19.0%
10% least volatile stocks in HK Market4.3%

İstikrarlı Hisse Senedi Fiyatı: 512 has not had significant price volatility in the past 3 months compared to the Hong Kong market.

Zaman İçindeki Volatilite: 512's weekly volatility (6%) has been stable over the past year.

Şirket Hakkında

KurulduÇalışanlarCEOWeb sitesi
199510,775Chao Zhouwww.grandpharm.com

Bir yatırım holding şirketi olan Grand Pharmaceutical Group Limited, farmasötik preparatlar ve tıbbi cihazlar, biyoteknoloji ve sağlık ürünleri ve farmasötik hammaddelerin araştırılması ve geliştirilmesi, üretimi ve satışı ile ilgilenmektedir. Şirket, solunum, oftalmoloji, serebro-kardiyovasküler acil ve biyoteknoloji ile ilgili ürünler sunmaktadır. Farmasötik, taurin, zirai kimyasallar, kimyasal ilaç ve amino asit serisi ürünler üretmekte ve satmaktadır.

Grand Pharmaceutical Group Limited Temel Bilgiler Özeti

Grand Pharmaceutical Group'un kazançları ve gelirleri piyasa değeriyle nasıl karşılaştırılır?
512 temel i̇stati̇sti̇kler
Piyasa değeriHK$15.97b
Kazançlar(TTM)HK$2.41b
Gelir(TTM)HK$10.59b

6.6x

F/K Oranı

1.5x

P/S Oranı

Kazanç ve Gelir

En son kazanç raporundan temel karlılık istatistikleri (TTM)
512 gelir tablosu (TTM)
GelirHK$10.59b
Gelir MaliyetiHK$4.34b
Brüt KârHK$6.25b
Diğer GiderlerHK$3.84b
KazançlarHK$2.41b

Son Raporlanan Kazançlar

Jun 30, 2024

Sonraki Kazanç Tarihi

n/a

Hisse başına kazanç (EPS)0.69
Brüt Marj59.00%
Net Kâr Marjı22.75%
Borç/Özkaynak Oranı28.1%

512 uzun vadede nasıl bir performans gösterdi?

Geçmiş performansı ve karşılaştırmayı görün

Temettüler

5.7%

Mevcut Temettü Verimi

38%

Ödeme Oranı